Medicare beneficiaries, particularly older women, are at greater risk of fractures from osteoporosis, which can lead to disability or death. These devastating consequences can be avoided if Medicare beneficiaries have access to recommended screening. Despite the demonstrated value of screening to patients and the Medicare program, CMS has cut reimbursement significantly for DXA testing. These cuts have had serious consequences – reversing a decade of prevention efforts and leading to an increase in hip fractures. AWIR supports legislative efforts to increase access to osteoporosis screening for patients by restoring previous Medicare reimbursement rates for DXA testing.